经食管超声心动图在心脏骤停中的应用:从急诊科到重症监护病房
心脏骤停是需快速诊断与治疗的高死亡率超急性病症,床旁超声(POCUS)已成为评估这类患者的有价值工具。经胸超声心动图(TTE)是查找可逆病因的更常规方式,而TOE因图像质量更优、可连续成像、操作可远离患者胸部而应用日益增多。TOE在心脏骤停后也有多项应用,如体外心肺复苏(ECPR)启动时及后续体外膜氧合(ECMO)监测。随着TOE发展,已衍生出多种不同用途的变体;本文综述支持TOE用于心脏骤停的证据,以及不同形式TOE如何及时准确评估心脏骤停患者。
要点
- TOE因图像质量优于TTE、可连续成像、操作可远离患者胸部,在心脏骤停评估中应用日益增多。
- TTE仍是查找心脏骤停可逆病因的更常规方式;TOE为替代/补充选择。
- TOE可用于ECPR启动时及后续ECMO监测。
- TOE已发展出多种变体,具有不同用途,可及时准确评估心脏骤停患者。
适用人群与场景
- 心脏骤停患者,涵盖急诊科至重症监护病房的救治场景。
研究设计与关键结果
- 综述指出,TOE因图像质量优于TTE、可连续成像且操作可远离患者胸部,在心脏骤停评估中应用日益增多。
- TOE可用于心脏骤停后ECPR启动时及后续ECMO监测。
- 随着TOE发展,已衍生出多种不同用途的变体。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Cardiac arrest is a hyper-acute condition with a high mortality that requires rapid diagnostics and treatment. As such, point-of-care ultrasound (POCUS) has become a valuable tool in the assessment of these patients. While transthoracic echocardiography (TTE) is the more conventional modality used to find reversible causes of cardiac arrest, transoesophageal echocardiography (TOE) has been increasingly utilised due to its superior image quality, continuous imaging, and ability to be operated away from the patient's chest. TOE also has a number of applications in the aftermath of cardiac arrest, such as during the initiation of extracorporeal cardiopulmonary resuscitation (ECPR) and the subsequent monitoring of extracorporeal membranous oxygenation (ECMO). As TOE has evolved, multiple variations have been developed with different utilities. In this article, we will review the evidence supporting the use of TOE in cardiac arrest and where the different forms of TOE can be applied to evaluate the cardiac arrest patient in a timely and accurate manner.
参考来源
- Edmiston T, Sangalli F, Soliman-Aboumarie H, et al. Transoesophageal echocardiography in cardiac arrest: From the emergency department to the intensive care unit. Resuscitation. 2024. PMID: 39174004. doi:10.1016/j.resuscitation.2024.110372
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。